Antares Pharma, Inc. (ATRS)

[Bio_pete]

The board of directors won't accept a takeover attempt if its just some sort of low ball offer. If the board votes to approve a takeover at $2 then that's probably all the company is worth even if investors are not happy. The company also has to obtain a majority of shareholder votes to approve the takeover.

The company never projected breakeven in the 4th qtr & the $200 - $300 million peak sales numbers are just estimates. Posters on the yahoo message board are the only ones projecting 4th qtr breakeven. The company hired an outside firm to survey rheumatologists & potential sales were extrapolated from those opinions. Most of these projections turn out to be wildly over optimistic for any number of reasons.

I know as much or as little as any retail ATRS investor & I have no idea how to value the company. Investors always think their investments are worth more but an opinion won't get you very far.

If Otrexup sales continue to increase then the company is undervalued but if they never achieve the breakeven level then the companies probably fairly valued at this point.

Funds are required to transmit holding on a semi-annual basis within 70 days of the qtr ending. Some funds do this on a qtrly basis.